{
 "name": "列特博",
 "slug": "tw-7725",
 "aliases": [
  "列特博生技股份有限公司",
  "LabTurbo",
  "7725"
 ],
 "ticker": "7725",
 "industry": "生技醫療業",
 "website": "http://www.labturbo.com.tw/",
 "summary": "列特博（7725）是興櫃的生技醫療類股公司，2019 年成立，2023 年登錄興櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "列特博生技股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "英文簡稱",
   "value": "LabTurbo",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心興櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "登錄興櫃日期",
   "value": "2023-12-22",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "成立日期",
   "value": "2019-06-12",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "董事長",
   "value": "戴子煌",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "總經理",
   "value": "戴極昇",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "實收資本額",
   "value": 483266330,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "資誠聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "公司網址",
   "value": "http://www.labturbo.com.tw/",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "主要產品：LabTurbo AIO",
   "value": "全流程全自動化核酸萃取基因檢測設備，整合萃取、試劑分注及qPCR偵測",
   "unit": "",
   "as_of": "2024-05-07",
   "source": "https://labturbo.com.tw/wp-content/uploads/2024/06/列特博_113年度股東會年報.pdf",
   "note": "112年度年報第38頁（PDF第42頁）；刊印日2024-05-07。"
  },
  {
   "claim": "主要產品：呼吸道病原多標的檢測及登革熱分型試劑",
   "value": "呼吸道病原多標的檢測及登革熱分型產品已在防疫市場銷售",
   "unit": "",
   "as_of": "2024-05-07",
   "source": "https://labturbo.com.tw/wp-content/uploads/2024/06/列特博_113年度股東會年報.pdf",
   "note": "年報第38頁；未將銷售事實推論為特定國家取得許可。"
  },
  {
   "claim": "主要產品：DNA及RNA核酸萃取試劑",
   "value": "手工或儀器用DNA及RNA核酸萃取試劑組及卡匣模組",
   "unit": "",
   "as_of": "2024-05-07",
   "source": "https://labturbo.com.tw/wp-content/uploads/2024/06/列特博_113年度股東會年報.pdf",
   "note": "年報第38頁；包含子公司惠晶產品。"
  },
  {
   "claim": "管線：QuadAIO（POCT分子檢測系統）",
   "value": "定點照護分子檢測｜完成開發、臨床前驗證｜地區未揭露",
   "unit": "",
   "as_of": "2024-05-07",
   "source": "https://labturbo.com.tw/wp-content/uploads/2024/06/列特博_113年度股東會年報.pdf",
   "note": "年報第2頁（PDF第6頁）；開發地區未揭露，沒有代填市場。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-22",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-7725.json",
 "generated_at": "2026-10-23T11:48:56.615Z"
}